Categories: Canada

Stock in Tylenol’s parent company rallies after Trump’s unproven claims – National


Shares of Tylenol maker Kenvue bounced back sharply before the opening bell a day after U.S. President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism.

“Don’t take Tylenol,” Trump instructed pregnant women around a dozen times during the White House news conference Monday, also urging mothers not to give their infants the drug, known by the generic name acetaminophen in the U.S. or paracetamol in most other countries.

Shares of the New Jersey consumer brands company tumbled 7.5 per cent Monday. Shares have regained most of those losses early Tuesday in premarket trading.

The announcement, which appeared to rely on existing studies rather than significant new research, arrives as Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine skeptic, advances the Make America Healthy Again movement that has focused on what it sees as potential causes of autism.

Story continues below advertisement




U.S. will identify cause of ‘autism epidemic’ by September, Kennedy says


Kenvue disputed any link between the drug and autism this week and warned that if pregnant mothers don’t use Tylenol when in need, they could face a dangerous choice between suffering fevers or using riskier alternatives.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.

Kenvue was spun off from Johnson & Johnson in 2023. Aside from Tylenol, the consumer health company makes Band-Aids, Listerine and other household brand names.

Citi Investment Research analyst Filippo Falorni wrote that he sees a limited risk of new lawsuits after Trump’s announcement, but thinks “there could be risk to Tylenol consumption given the negative headlines.”

The company has fought hundreds of lawsuits related to the product and its alleged ties to autism, but most have been dismissed.

The analyst anticipates a positive reaction for Kenvue’s stock at the opening bell on Tuesday given the lack of new scientific evidence.

Story continues below advertisement

Shares of Kenvue Inc., based in Summit, New Jersey, climbed over seven per cent in premarket trading.


&copy 2025 The Canadian Press



Source link

admin2

Share
Published by
admin2

Recent Posts

Market Volatility Just Put Small-Cap Stocks on Sale

Small-cap stocks are the most attractively valued capitalization segment of the U.S. equity market right…

2 minutes ago

Proposed Saskatoon bylaw aims to address safety concerns on city buses – Saskatoon

Changes aimed at addressing safety concerns on Saskatoon city buses could be on the way.…

14 minutes ago

Zidane Iqbal: The footballer who gave Pakistan its first World Cup moment | World Cup 2026

Islamabad, Pakistan – The scoreline read 4-1 to Norway. Iraq had been heavily beaten in…

23 minutes ago

Sam Bankman-Fried Wants A New Token To Repay FTX Victims, But Could It Happen?

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure Sam Bankman-Fried…

33 minutes ago

‘I’m very sorry’: Accused in seawall stranger attack seeks not criminally responsible finding – BC

Counsel for a man accused of attacking a tourist on Vancouver’s seawall last year is…

3 hours ago

JPMorgan Converts $950M to Active NY, CA Muni ETFs

This week J.P. Morgan Asset Management launched two actively managed municipal bond ETFs focused on…

5 hours ago